Clinical trial
A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
NCT00287235 is registered in ClinicalTrials.gov with Vantive Health LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Controlled Study Of The Clinical Efficacy Of Albumin Dialysis Using The Molecular Adsorbent Recirculating System (MARS®) For The Treatment Of Patients With Hepatic Encephalopathy
- Lead sponsor
- Vantive Health LLC
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 30, 2000
- Completion date
- April 30, 2004
- Enrollment
- 70 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.